Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
On October 2, the European Medicines Agency ("EMA") published a new policy on the proactive disclosure of clinical data submitted by pharmaceutical companies in the context of marketing authorization applications.
On October 2, the European Medicines Agency ("EMA")
published a new policy on the proactive disclosure of
clinical data submitted by pharmaceutical companies in the context
of marketing authorization applications. The policy would allow the
EMA to publish such data after marketing authorization has been
granted, and companies would have to redact the submitted dossier
for personal data of doctors and patients.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
